"The EAC remains the most diverse and interactive antibody meeting”

Advisory Board

Dario Neri, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology ZurichDario Neri Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich

Roy Baynes, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD) Roy Baynes
SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)

M. Anthony Moody, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre M. Anthony Moody
Associate Professor, Department of Paediatrics, Division of Infectious Diseases
Duke University Medical Centre

Frédéric Triebel, Chief Scientific Officer, Chief Medical Officer, Prima BioMed Frédéric Triebel
Chief Scientific Officer, Chief Medical Officer Prima BioMed

Shane Olwill, Head of Immuno-Oncology, Pieris Pharmaceuticals Shane Olwill
Head of Immuno-Oncology
Pieris Pharmaceuticals

Alain Vertes, Managing Director, NxR Biotechnologies Alain Vertes
Managing Director
NxR Biotechnologies

Joern Schmitz, Head, Department of Immunotherapy, Fraunhofer IME Joern Schmitz
Head, Department of Immunotherapy
Fraunhofer IME

800+ Attendees | 300+ Speakers | 600+ 1-2-1 Meetings

Sign Up for Event Updates

Congress Topics

Cell therapy

  • Antigen Targets
  • Cell Therapy for solid tumours
  • Allogeneic gene therapy

Oncolytic viral therapy and cancer vaccines

  • Early stage discovery
  • Technological breakthroughs

Combination therapy

  • Current development
  • Case studies
  • Lessons learned
  • Challenges

Immunotherapy for solid tumours

  • Challenges for solid tumours
  • Examples and pre/clinical development

Immune checkpoint inhibitors

  • Approved Market Formats
  • New Agents
  • Combination Agents

Market access

  • Investor input
  • Regulatory issues
  • Commercialisation and manufacture

Clinical trials

  • Workshops
  • Challenges with clinical trials
  • Case studies

Biomarkers

  • Technology
  • Development
  • New biomarkers in development
  • Linker technology

Co-located with 

World Biosimilar congress

European Antibody Congress

HPAPI World Congress

Part of

Festival of Biologics

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sponsors & Exhibitors

 

  • Gold Sponsor

    MabDesign at World Immunotherapy Congress

    Exhibitor

    MUNIT at World Immunotherapy Congress

    Associate Sponsor

    Lonza at World Immunotherapy Congress
  • Associate Sponsor

    Food Pharma Systems at World Immunotherapy Congress

    Gold Sponsor

    Retrogenix at World Immunotherapy Congress

    Gold Sponsor

    Fujifilm Diosynth Biotechnologies U.S.A., Inc. at World Immunotherapy Congress
  • Silver Sponsor

    Sartorius Stedim Biotech U.K. at World Immunotherapy Congress

    Silver Sponsor

    ACRO Biosystems Inc at World Immunotherapy Congress

    Silver Sponsor

    MaxCyte at World Immunotherapy Congress
  • Silver Sponsor

    Isogenica Ltd at World Immunotherapy Congress

    Associate Sponsor

    Abzena at World Immunotherapy Congress

    Associate Sponsor

    Bioreclamationivt at World Immunotherapy Congress
  • Associate Sponsor

    AbCheck at World Immunotherapy Congress

    Partner

    Canton of Basel-Stadt at World Immunotherapy Congress

    Exhibitor

    MInakem High Potent at World Immunotherapy Congress
  • Exhibitor

    I and L Biosystems at World Immunotherapy Congress

    Exhibitor

    Aldevron at World Immunotherapy Congress

    Exhibitor

    BioRad at World Immunotherapy Congress
  • Exhibitor

    Bio-Techne at World Immunotherapy Congress

    Exhibitor

    DiscoverX Corporation Ltd at World Immunotherapy Congress

    Exhibitor

    Groupe NOVASEP at World Immunotherapy Congress
 

World Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy Congress
World Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy Congress

Testimonials

 

Pierre Fabre

"The EAC, managed by a very professional team, is a unique meeting that brings the entire mAbs stakeholder together with excellent speakers and sufficient time for networking.

Alain Beck 
Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Sanofi

Good science, wide industrial and academic representation, great organization! ” 

Alexey Rak
Head of Biostructure and Biophysics
Sanofi

Uiversity Hospital Basel

"Great meeting, top speaker, perfect location, accomodation and catering "  

Frank Stenner 
Oncologist,  University Hospital Basel

Cancer Research UK Cambridge Institut

“Great depth and variety with engaging open discussions across industry/academic and biotech ” 

Sidath Katugampola
Biomarker Development Specialist
Cancer Research UK Cambridge Institute  

Sign Up for Event Updates